FDA approves first drug for inherited breast cancer
AstraZeneca PLC's Lynparza is for patients with inherited BRCA gene mutations who have undergone chemotherapy
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news
More News: AstraZeneca | Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Genetics | Health